The changing frequency of celiac disease diagnosed at the Stollery Children's Hospital

Seema Rajani1, Hien Q Huynh, Justine Turner

  • 1Division of Gastroenterology and Nutrition, Department of Pediatrics, University of Alberta, Edmonton, Canada.

Insights

Pediatric celiac disease (CD) diagnoses surged 11-fold, with nearly half presenting atypical symptoms. Early diagnosis and gluten avoidance significantly improve health outcomes in children with CD.

Area of Science:

  • Pediatric Gastroenterology
  • Autoimmune Disorders
  • Clinical Research

Background:

  • Celiac disease (CD) is a prevalent autoimmune gastrointestinal disorder in children.
  • Early diagnosis of CD in childhood is linked to improved health outcomes.
  • Increased awareness of diverse extraintestinal symptoms contributes to rising CD prevalence.

Purpose of the Study:

  • To investigate temporal trends in pediatric celiac disease diagnoses.
  • To assess the association between increased CD diagnoses and atypical presentations.
  • Study conducted at Stollery Children's Hospital, Edmonton, Alberta.

Main Methods:

  • Retrospective chart review of biopsy-proven CD cases from 1998-2007.
  • Data collection included demographics, symptoms, risk factors, and lab investigations.
  • Analysis focused on diagnostic frequency and symptom profiles.

Main Results:

  • A significant increase in CD diagnoses observed, particularly after January 2003.
  • The number of diagnoses rose 11-fold in the last four years of the study.
  • 46% of children diagnosed post-2003 presented with absent or atypical symptoms; 96% reported symptom improvement.

Conclusions:

  • Increased screening and diagnosis of atypical CD cases contributed to higher numbers.
  • Early identification and lifelong gluten avoidance are crucial for pediatric CD management.
  • Prompt diagnosis and dietary management offer substantial health benefits for children with celiac disease.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...